Biomarker prevalence study and phase I trial of afatinib in children with malignant tumours

Authors :: Isabelle Aerts
Birgit Geoerger
Guy Makin
Mark W. Kieran
Pamela Kearns
B. Stolze
M. Gambart
Karsten Nysom
A. Lahogue
Darren Hargrave
P. Leblond
Didier Frappaz
Pascale Varlet
Michela Casanova
Lynley V. Marshall
Sven Wind
S. Gallego
D. Roy
F. Giangaspero
Martina Uttenreuther-Fischer
Source :: Annals of Oncology. 28:v23
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Afatinib
medicine
Cancer
Hematology
medicine.disease
business
medicine.drug

Full Text Access

Tools